Validation of the Greek version of the distress thermometer compared to the clinical interview for depression

Author:

Kyranou M.ORCID,Varvara C.,Papathanasiou M.,Diakogiannis Ι.,Zafeiropoulos K.,Apostolidis M.,Papandreou C.,Syngelakis M.

Abstract

Abstract Background The Distress Thermometer (DT) is worldwide the most commonly used instrument for quick screening of emotional burden in patients with cancer. In order to validate the Greek version of the DT in the Greek population we aimed to explore the capacity of the DT to identify patients with comorbid depressive diagnosis. Methods We analyzed the routinely collected clinical data from 152 patients with cancer who had been evaluated by the consultation-liaison psychiatric service and had received a diagnosis of either depressive disorder or no psychiatric diagnosis. The score of the DT accompanied by the list of problems in the Problem List, the depression status, and the clinical and demographic characteristics entered the data sheet. Results The ROC analysis revealed that the DT achieved a significant discrimination with an area under the curve of 0.79. At a cut-off point of 4, the DT identified 85% of the patients with an ICD-10 depressive diagnosis (sensitivity) and 60% of the patients without a psychiatric diagnosis (specificity). The positive predictive value was 44%, the negative predictive value 92% and the diagnostic odd ratio 8.88. Fatigue and emotional difficulties were the most commonly reported problems by the patients. Conclusion The Greek version of the DT has a sufficient overall accuracy in classifying patients regarding the existence of depressive disorders, in the oncology setting. Therefore, it can be considered as a valid initial screening tool for depression in patients with cancer; patients scoring ≥4 should be assessed by a more thorough mental evaluation.

Publisher

Springer Science and Business Media LLC

Subject

Psychiatry and Mental health

Reference33 articles.

1. Wild CP, Ferlay J, Soerjomatarm I, Bray F. The global cancer burden 2018: Implications for cancer prevention and control: World Cancer Congress; 2018. Presented October 2, 2018. Available at: https://www.worldcancercongress.org/sites/congress/files/atoms/files/Plenary%201_presentations.pdf. Accessed 30 Nov 2019.

2. World Health Organization, International Agency for Research on Cancer. Source: The Global Cancer Observatory (Globocan 2018); Greece cancer report. 2020. Available at: https://gco.iarc.fr/today/data/factsheets/populations/300-greece-fact-sheets.pdf. Accessed 30 July 2020.

3. Referenced with permission from the NCCN Guidelines® for Distress Management V.3.2019© National Comprehensive Cancer Network, Inc. 2019. All rights reserved. Accessed Nov 30, 2019. Available online at https://www.nccn.org. NCCCN makes no warranties of any kind whatsoever regarding their content, use or application and disclaims any responsibility for their application or use in any way.

4. Holland JC, Andersen B, Breitbart WS, Dabrowski M, Dudley MM, Fleishman S, Foley GV, Fulcher C, Greenberg DB, Greiner CB, Handzo RG, Jacobsen PB, Knight SJ, Learson K, Levy MH, Manne S, McAllister-Black R, Peterman A, Riba MB, Slatkin NE, Valentine A, Zevon MA. NCCN. Distress management: clinical practice guidelines in oncology™. JNCCN. 2007;5(1):66–98.

5. National Comprehensive Cancer Network. Patients and caregiving Recourses: Managing Stress and Distress. Available at: https://www.nccn.org/patients/resources/life_with_cancer/distress.aspx. Accessed Nov 30, 2019.

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3